Related Experiment Video

Updated: Jul 18, 2026

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

Influence of small interfering RNA corresponding to ets homologous factor on senescence-associated modulation of

Chaehwa Park1, Inkyoung Lee, Won Ki Kang

  • 1Cancer Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-Dong, Seoul 135-710, Korea. cpark@smc.samsung.co.kr

Molecular Cancer Therapeutics
|December 19, 2006
PubMed

Insights

Ets homologous factor (EHF) suppresses senescence and promotes drug resistance in prostate cancer. Inhibiting EHF halts cancer cell proliferation and shrinks tumors, suggesting EHF as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Cellular senescence is a key tumor-suppressive mechanism.
  • Identifying genes that regulate senescence is crucial for cancer research.
  • Ets homologous factor (EHF) was found to be suppressed in senescent cancer cells.

Purpose of the Study:

  • To investigate the role of EHF in prostate cancer progression.
  • To determine if EHF influences cellular senescence and drug resistance.
  • To evaluate EHF as a potential therapeutic target in cancer.

Main Methods:

  • Utilized small interfering RNA (siRNA) to knockdown EHF expression in PC-3 prostate cancer cells.
  • Assessed cell proliferation, senescence markers (Rb, p27, cyclin A, cdc2, E2F1), and telomerase activity.
  • Performed in vivo tumorigenesis assays to evaluate the effect of EHF knockdown on tumor growth.

Main Results:

  • EHF knockdown inhibited proliferation and induced premature senescence, characterized by specific molecular changes.
  • Transient EHF knockdown decreased telomerase activity, while EHF overexpression increased it.
  • In vivo studies showed significantly smaller tumors from EHF knockdown cells and reduced pre-established tumors upon EHF siRNA injection.

Conclusions:

  • Aberrant EHF expression disrupts p27-mediated senescence and telomerase activity, contributing to tumor progression.
  • EHF plays a significant role in promoting drug resistance and tumor growth in prostate cancer.
  • EHF represents a promising therapeutic target for future cancer treatments.

More Related Videos

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)

Published on: May 16, 2012

miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...